期刊文献+

局部枸橼酸抗凝在地震挤压伤患者CRRT治疗中的应用观察 被引量:3

Clinical Observation of Local Citrate Anticoagulation in Crush Syndrome Patients Undergoing CRRT after Earthquake
原文传递
导出
摘要 目的:分析局部枸橼酸抗凝在地震挤压伤患者CRRT治疗中的效果和安全性,并比较不同实施方式的差异。方法:回顾性的分析汶川地震后我院收治的因挤压伤而接受CRRT治疗的患者中局部枸橼酸抗凝的情况。共计39例患者因挤压伤和多器官功能障碍而接受局部枸橼酸抗凝CRRT治疗。按照不同的实施方式分为A组(23例)以同步输入方式进行,B组(16例)以预充式进行。治疗过程中监测患者的肝肾功能、电解质、凝血指标、血常规等。分析不同治疗组局部枸橼酸抗凝治疗的效果和安全性。结果:39例患者死亡4例,其余35例均康复。存活患者治疗后SCr和BUN指标均较治疗前明显降低,差异有统计学意义,Scr:A组(503±215)μmol/L对(149±129.7)μmol/L,B组(577±227)μmol/L对(180.6±146.5)μmol/L,P<0.05;BUN:A组(26.6±10.4)mmol/L对(9.3±6.9)mmol/L,B组(30.5±8.1)mmol/L对(10.9±5.72)mmol/L,P<0.05。两组滤器后ACT值均较外周血ACT值明显延长且差异有统计学意义,A组:(161±31)s对(122±25)s,B组:(157±33)s对(125±31)s,P<0.05。A组滤器和管路寿命(47.6±11.2)h与B组(41.3±14.5)h相近,A组略长于B组,但两组差异无统计学意义(P>0.05)。其他凝血指标差异无统计学意义。在治疗过程中未发生严重电解质和酸碱平衡紊乱。结论:局部枸橼酸抗凝适于地震挤压伤患者CRRT治疗,这种抗凝方式抗凝效果确切,而且不会加重患者的凝血功能紊乱,不会增加患者活动性出血的风险。同步式局部枸橼酸抗凝在延长滤器和管路方法可能优于预充方式。 Objective: To analysis the efficacy and safety of local citrate anticoagulation in patients with crush syndrome undergoing CRRT after earthquake, and to compare the differences of 2 anticoagulation ways. Methods: The crush syndrome patients received local citrate anticoagulation CRRT after Wenchuan Earthquake were analysed. Thirty-nine patients were divided into 2 groups according the citrate anticoagulation Methods: Group A (n=23) using the WARD method, Group B (n= 16) using Palsson method. Liver and renal function, electrolytes level, coagulation indexes were monitored during treatment. Results: Four cases died during treatment. Serum creatinine and BUN levels were significantly lowed after treatment (Scr: Group A 503±215 μmol/L vs 149±129.7 μmol/L, B 577±227 μmol/L vs 180.6± 146.5 μmol/L, P〈0.05; BUN: Group A 26.6±10.4 mmol/L vs 9. 3±6.9 mmol/L, Group B 30.5± 8.1 mmol/L vs 10.9±5.72 mmol/L, P〈0.05). Post filter ACT were significant longer than peripheral ACT in both groups (Group A: 161±31 s vs 122±25 s, Group B2: 157±33 s vs 125±31 s, P〈0.05). Filter and circus run time in group A was slightly longer than group B, although no significant difference was noticed in both groups. Conclusion.. Local citrate anticoagulation is suitable to crush syndrome patients undergoing CRRT.
出处 《华西医学》 CAS 2009年第7期1808-1811,共4页 West China Medical Journal
关键词 局部枸橼酸抗凝 CRRT 挤压综合征 local citrate anticoagulation CRRT crush syndrome
  • 相关文献

参考文献7

  • 1VANHOLDER R, et al. Earthquakes and crush syndrome casualties: lessons learned from the Kashmir disaster [J]. Kidney Int, 2007,71(1): 17-23.
  • 2ODA Y, etal. Crush syndrome sustained in the 1995 Kobe, Japan, earthquake; treatment and outcorne[J]. Ann Emerg Med, 1997,30(4):507-512.
  • 3KUTSOGIANNIS D J, et al. Regional citrate anticoagulation in continuous venovenous hemodiafiltration[J]. Am J Kidney Dis, 2000,35(5):802-811.
  • 4龚德华,季大玺,徐斌,谢红浪,刘云,黎磊石.在严重出血倾向重危患者应用枸橼酸抗凝进行连续性静脉-静脉血液滤过治疗[J].肾脏病与透析肾移植杂志,2002,11(6):510-514. 被引量:39
  • 5苏白海,秦伟,付平,崔天蕾,米绪华.预冲式枸橼酸钠抗凝技术在连续性血液净化高危出血患者中的应用[J].西部医学,2008,20(2):267-270. 被引量:13
  • 6PALSSON R, JL. Niles, Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding[J]. Kidney Int, 1999,55(5):1991-1997.
  • 7SCHMITZ M, et al. Continuous venovenous haemofiltration using a citrate buffered substitution fluid [J]. Anaesth Intensive Care, 2007,35 (4) : 529-535.

二级参考文献17

  • 1Palsson R,Niles JL.Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.Kidney Int,1999,55:1991
  • 2Tolwani JA,Campbell RC,Schenk MB et al.Simplified citrate anticoagulation for continuous renal replacement therapy.Kidney Int,2001,60:370
  • 3Janssen MJ,Huijgens PC,Bouman AA et al.Citrate versus heparin anticoagulation in chronic hemodialysis patients.Nephrol Dial Transplant,1993,8(11):1228
  • 4Kirschbaum B,Galishoff M,Reines HD.Lactic acidosis treated with continuous hemodiafiltration and regional citrate anticoagulation.Crit Care Med,1992,20(3):349
  • 5Meulen JVD,Janssen MJFM,Langendijk PNJ et al.Citrate anticoagulation and dialysate with reduced buffer content in chronic hemodialysis.Clin Nephrol,1991,37(1):36
  • 6Kutsogiannis DJ,Mayers I,Chin WDN et al.Regional citrate anticoagulation in continuous venovenous hemodiafiltration.Am J Kidney Dis,2000,35(5):802
  • 7Oberbauer R,Fabrizii V,Drumal W et al.Acute acid-base disorder during plasma immunoadsorption treatment using citrate anticoagulation.Nephrol Dial Transplant,1998,13(6):1581
  • 8Sramek V,Novk I,Matějovi M et al.Continuous venovenous hemodiafiltation (CVVHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure,hypercalcemia,and thrombocytopenia.Intens Care Med,1998,24:262
  • 9Dhondt A,Vanholder R,Tielemans C et al.Effect of regional citrate anticoagulation on leukopenia,complement activation,and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes.Nephron,2000,85(4):334
  • 10Bohler J,Schollmeyer P,Dressel B et al.Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation:Dissociation of complement activation and neutropenial from neutrophil degranulation.J Am Soc Nephrol,1996,7:234

共引文献49

同被引文献30

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部